Growth and productivity improvements in the medical and industrial gas business
First written in FY2016. 12 of 37 entries say "Advanced", first in FY2019-Q1. Latest entry: 2026-10-29.
No other company in this theme has enough history to compare yet.
- FY2026Full-Year Revenue and Profit GrowthAnnual report
「As a result, revenue in this business was ¥8,963 million, up ¥819 million from the previous consolidated fiscal year.」
Revenue increased for the full year due to higher rentals and sales of home-care medical equipment and other factors, while segment profit rose 1.3% year on year to ¥473 million. - 2026-05-14Cited as achievedEarnings
「在宅医療機器のレンタルや販売が増加したこと等により、売上高は、8,963百万円と前連結会計年度と比べ819百万円（10.1％）の増収となりました。」
医療・産業ガス事業について、在宅医療機器のレンタル・販売増加による増収と、セグメント利益の増益を実績として示している。 - FY2026-H1Medical and Industrial Gases business: revenue increased but profit declined in the first halfAnnual report
「In this segment, revenue was ¥4,382 million, up ¥433 million, or 11.0%, from the same period of the previous year, mainly due to increased rentals and sales of home-care medical equipment and higher sales in the Industrial Gases and Equipment division. Although gross profit increased with higher revenue, higher SG&A expenses resulted in segment profit (operating profit) of ¥230 million, down ¥16 million, or 6.7%, from the same period of the previous year.」
Revenue increased 11.0% on higher sales of home-care medical equipment, industrial gases and equipment, while operating profit declined 6.7% due to higher SG&A expenses. - FY2025-H1Interim revenue and profit growthAnnual report
「In this segment, revenue was ¥3,948 million, up ¥425 million, or 12.1%, from the same period of the previous year, mainly due to increased rentals and sales of home-care medical equipment. Gross profit also increased with higher revenue, and despite higher SG&A expenses, segment profit (operating profit) was ¥246 million, up ¥93 million, or 60.9%, from the same period of the previous year.」
Increased rentals and sales of home-care medical equipment and other factors resulted in a 12.1% increase in revenue and a 60.9% increase in operating profit in the Medical and Industrial Gases business. Revenue and profit increased in the first half, following declines in both for the full previous fiscal year. - FY2024Full-Year Revenue and Profit DeclineAnnual report
「As a result, revenue in this business was ¥7,321 million, down ¥117 million from the previous consolidated fiscal year. As a result, although gross profit in this business increased, SG&A expenses also rose, resulting in segment profit (operating profit) of ¥349 million, down ¥56 million, or 13.9%, from the previous consolidated fiscal year.」
For the full year, revenue in the Medical and Industrial Gases business declined by ¥117 million, or 1.6%, and operating profit also decreased by ¥56 million, or 13.9%. - FY2024-Q3Lower Nine-Month Sales and ProfitAnnual report
「In this segment, revenue was ¥5,400 million, down ¥59 million, or 1.1%, from the same quarter of the previous year, mainly due to lower sales of home-care medical equipment. Although gross profit increased with higher revenue in the Industrial Gases and Equipment division, higher SG&A expenses resulted in segment profit (operating profit) of ¥240 million, down ¥56 million, or 19.1%, from the same quarter of the previous year.」
Lower sales of home-care medical equipment and higher SG&A expenses resulted in a 1.1% decline in revenue and a 19.1% decline in operating profit in the Medical and Industrial Gases business. - FY2024-Q2Lower Six-Month Sales and ProfitAnnual report
「In this segment, revenue was ¥3,522 million, down ¥90 million, or 2.5%, from the same quarter of the previous year, mainly due to lower sales of home-care medical equipment. Although gross profit increased with higher revenue in the Industrial Gases and Equipment division, higher SG&A expenses resulted in segment profit (operating profit) of ¥153 million, down ¥24 million, or 13.8%, from the same quarter of the previous year.」
Lower sales of home-care medical equipment and higher SG&A expenses resulted in a 2.5% year-on-year decline in revenue and a 13.8% decline in operating profit in the Medical and Industrial Gases business. - FY2024-Q1First-Quarter Sales and Profit DeclineAnnual report
「In this segment, sales of home healthcare equipment and medical gases decreased, among other factors, resulting in revenue of ¥1,735 million, down ¥29 million, or 1.7%, from the same quarter of the previous year. Although gross profit increased in the industrial gas and equipment division alongside higher revenue, increased SG&A expenses resulted in segment profit (operating profit) of ¥67 million, down ¥21 million, or 23.7%, from the same quarter of the previous year.」
Declines in sales of home-care medical equipment and higher SG&A expenses resulted in a 1.7% decline in revenue and a 23.7% decline in operating profit in the Medical and Industrial Gases business. - FY2023AdvancedAnnual report
「As a result, revenue for this business was ¥7,438 million, up ¥432 million from the previous consolidated fiscal year.」
The medical and industrial gas business recorded higher revenue on increased rentals of home healthcare equipment and sales of medical gases, industrial gases and equipment, while segment profit increased 22.4% year on year to ¥405 million. - FY2023-Q3AdvancedAnnual report
「In this segment, sales of rentals of home healthcare equipment, including oxygen concentrators, and industrial gases and industrial equipment increased, among other factors, resulting in revenue of ¥5,460 million, up ¥304 million, or 5.9%, from the same quarter of the previous year. Gross profit also increased with higher revenue, among other factors, resulting in segment profit (operating profit) of ¥297 million, up ¥41 million, or 16.0%, from the same quarter of the previous year.」
Revenue increased 5.9% on higher rentals of home healthcare equipment and sales of industrial gases and industrial equipment, while operating profit also increased 16.0%. - FY2023-Q2AdvancedAnnual report
「In this segment, sales of rentals of home healthcare equipment, including oxygen concentrators, and industrial gases and industrial equipment increased, among other factors, resulting in revenue of ¥3,613 million, up ¥220 million, or 6.5%, from the same quarter of the previous year. Gross profit also increased with higher revenue, among other factors, resulting in segment profit (operating profit) of ¥178 million, up ¥26 million, or 17.2%, from the same quarter of the previous year.」
Revenue increased 6.5% on higher rentals of home healthcare equipment and sales of industrial gases and industrial equipment, while segment profit also increased 17.2%. - FY2023-Q1AdvancedAnnual report
「In this segment, sales of rentals of home healthcare equipment, including oxygen concentrators, and industrial gases and industrial equipment increased, among other factors, resulting in revenue of ¥1,764 million, up ¥120 million, or 7.3%, from the same quarter of the previous year. Gross profit also increased with higher revenue, among other factors, resulting in segment profit (operating profit) of ¥88 million, up ¥18 million, or 27.2%, from the same quarter of the previous year.」
Revenue increased 7.3% on higher rentals of home healthcare equipment and sales of industrial gases and industrial equipment, while operating profit also increased 27.2%. - FY2022AdvancedAnnual report
「From the current consolidated fiscal year, the former “Home Healthcare and Medical Gas Division” has been divided into the “Home Healthcare Division” and the “Medical Gas Division” following a change in the company’s organisational structure, with the aim of improving operating efficiency by subdividing departments by product category. Segment profit (operating profit) was ¥331 million, up ¥207 million, or 167.5%, from the previous consolidated fiscal year.」
Operating efficiency was improved by subdividing the organisation by product category, and the medical and industrial gas business recorded operating profit of ¥331 million, up 167.5% from the previous fiscal year, in addition to higher revenue. - FY2022-Q3AdvancedAnnual report
「In this segment, sales of rentals of home healthcare equipment, including oxygen concentrators, and medical gases, including medical oxygen, increased, among other factors, resulting in revenue of ¥5,155 million, up ¥494 million, or 10.6%, from the same quarter of the previous year. Gross profit also increased with higher revenue, among other factors, resulting in segment profit (operating profit) of ¥255 million, up ¥181 million, or 241.7%, from the same quarter of the previous year.」
Revenue increased 10.6% on higher rentals of home healthcare equipment and sales of medical gases, among other factors, while operating profit rose 241.7% year on year to ¥255 million. - FY2022-Q2Higher revenue, higher profitAnnual report
「In this segment, sales of rentals of home healthcare equipment, including oxygen concentrators, and medical gases, including medical oxygen, increased, among other factors, resulting in revenue of ¥3,393 million, up ¥352 million, or 11.6%, from the same quarter of the previous year. Gross profit also increased with higher revenue, among other factors, resulting in segment profit (operating profit) of ¥151 million, up ¥115 million, or 315.4%, from the same quarter of the previous year.」
Revenue increased 11.6% on higher rentals of home healthcare equipment and sales of medical gases, while operating profit rose 315.4% year on year to ¥151 million. - FY2022-Q1Revenue growth and return to operating profitabilityAnnual report
「In this segment, sales of rentals of home healthcare equipment, including oxygen concentrators, and medical gases, including medical oxygen, increased, among other factors, resulting in revenue of ¥1,644 million, up ¥176 million, or 12.1%, from the same quarter of the previous year. Gross profit also increased with higher revenue, among other factors, resulting in segment profit (operating profit) of ¥69 million, compared with a loss of ¥6 million in the same quarter of the previous year.」
Revenue increased 12.1% on higher rentals of home healthcare equipment and sales of medical gases, and the segment moved from an operating loss of ¥6 million in the previous year to operating profit of ¥69 million. - FY2021-Q3Revenue growth, but earnings decline continuesAnnual report
「In this segment, sales of rentals of home healthcare equipment, including oxygen concentrators, increased. Revenue from 近畿酸器㈱ was also consolidated from the third quarter of the previous fiscal year, among other factors, resulting in revenue of ¥4,660 million, up ¥967 million, or 26.2%, from the same quarter of the previous year. Although gross profit also increased with higher revenue, increased SG&A expenses at 近畿酸器㈱ and goodwill amortisation resulted in segment profit (operating profit) of ¥74 million, down ¥41 million, or 35.9%, from the same quarter of the previous year.」
Revenue increased following the consolidation of 近畿酸器㈱, while higher SG&A expenses at the company and goodwill amortisation reduced operating profit by 35.9%. - FY2021-Q2Revenue growth, but earnings decline continuesAnnual report
「In this segment, sales of rentals of home healthcare equipment, including oxygen concentrators, increased. Revenue from 近畿酸器㈱ was also consolidated from the third quarter of the previous fiscal year, among other factors, resulting in revenue of ¥3,040 million, up ¥973 million, or 47.1%, from the same quarter of the previous year. Although gross profit also increased with higher revenue, increased SG&A expenses at 近畿酸器㈱ and goodwill amortisation resulted in segment profit (operating profit) of ¥36 million, down ¥46 million, or 56.1%, from the same quarter of the previous year.」
The medical and industrial gas business recorded 47.1% revenue growth following the consolidation of 近畿酸器㈱, while operating profit decreased 56.1% due to higher SG&A expenses at the company and goodwill amortisation. - FY2021-Q1Higher revenue but a shift to an operating lossAnnual report
「In this segment, sales of rentals of home healthcare equipment, including oxygen concentrators, increased. Revenue from 近畿酸器㈱ was also consolidated from the third quarter of the previous fiscal year, among other factors, resulting in revenue of ¥1,467 million, up ¥501 million, or 51.8%, from the same quarter of the previous year. Although gross profit also increased with higher revenue, increased SG&A expenses at 近畿酸器㈱ and goodwill amortisation resulted in a segment loss (operating loss) of ¥6 million, compared with profit of ¥22 million in the same quarter of the previous year.」
Revenue increased 51.8% following the consolidation of 近畿酸器㈱, while higher SG&A expenses and goodwill amortisation resulted in a shift from operating profit in the previous year to an operating loss of ¥6 million. - FY2020Higher revenue coexisted with lower profit due to M&A-related expensesAnnual report
「As a result, revenue for this business was ¥5,268 million, up ¥1,232 million from the previous fiscal year. Although gross profit also increased with higher revenue, increased SG&A expenses at 近畿酸器㈱, which became a consolidated subsidiary during the current fiscal year, and goodwill amortisation resulted in segment profit (operating profit) of ¥81 million, down ¥31 million, or 28.1%, from the previous fiscal year.」
The medical and industrial gas business recorded 30.5% revenue growth following the consolidation of 近畿酸器㈱, while operating profit decreased 28.1% due to the subsidiary’s SG&A expenses and goodwill amortisation. - FY2020-Q3AdvancedAnnual report
「In this segment, sales of home healthcare equipment, including oxygen concentrators, medical gases, industrial gases, equipment and construction increased. Revenue from 近畿酸器㈱, which became a subsidiary during the current fiscal year, also contributed, resulting in revenue of ¥3,693 million, up ¥684 million, or 22.7%, from the same quarter of the previous year. Gross profit also increased with higher revenue. Despite higher SG&A expenses including selling and personnel costs, segment profit (operating profit) was ¥116 million, up ¥53 million, or 86.0%, from the same quarter of the previous year.」
The medical and industrial gas business recorded 22.7% revenue growth, partly due to the contribution from 近畿酸器㈱, while segment profit increased 86.0% year on year to ¥116 million. - FY2020-Q2AdvancedAnnual report
「In this segment, sales of home healthcare equipment, including oxygen concentrators, medical gases, industrial gases, equipment and construction increased, resulting in revenue of ¥2,066 million, up ¥128 million, or 6.6%, from the same quarter of the previous year. Gross profit also increased with higher revenue. Although SG&A expenses including selling and personnel costs increased, segment profit (operating profit) was ¥83 million, up ¥43 million, or 111.6%, from the same quarter of the previous year.」
The medical and industrial gas business recorded higher revenue, while operating profit increased 111.6% year on year to ¥83 million. - FY2020-Q1AdvancedAnnual report
「In this segment, sales of home healthcare equipment, including oxygen concentrators, medical gases, industrial gases, equipment and construction increased, resulting in revenue of ¥966 million, up ¥33 million, or 3.6%, from the same quarter of the previous year. Gross profit also increased with higher revenue. Although SG&A expenses including selling and personnel costs increased, segment profit (operating profit) was ¥22 million, up ¥12 million, or 132.5%, from the same quarter of the previous year.」
The medical and industrial gas business recorded higher revenue, while operating profit increased 132.5% year on year to ¥22 million. - FY2019-Q3AdvancedAnnual report
「In this segment, sales in each category of home healthcare equipment, including oxygen concentrators, medical gases, industrial gases, equipment and construction remained strong. Revenue was ¥3,009 million, up ¥340 million, or 12.7%, from the same quarter of the previous year. Gross profit also increased with higher revenue. Despite higher personnel and other costs to strengthen sales capabilities, segment profit (operating profit) was ¥62 million, compared with a loss of ¥36 million in the same quarter of the previous year.」
Revenue increased 12.7% on sales across all categories, and the segment moved from an operating loss of ¥36 million in the same quarter of the previous year to operating profit of ¥62 million. - FY2019-Q2AdvancedAnnual report
「In this segment, sales in each category of home healthcare equipment, including oxygen concentrators, medical gases, industrial gases, equipment and construction remained strong. Revenue was ¥1,938 million, up ¥189 million, or 10.8%, from the same quarter of the previous year. Gross profit also increased with higher revenue. Despite higher personnel and other costs to strengthen sales capabilities, segment profit (operating profit) was ¥39 million, compared with a loss of ¥8 million in the same quarter of the previous year.」
Revenue increased 10.8% on sales across all categories, and the segment moved from an operating loss of ¥8 million in the same quarter of the previous year to operating profit of ¥39 million. - FY2019-Q1AdvancedAnnual report
「In this segment, sales in each category of home healthcare equipment, including oxygen concentrators, medical gases, industrial gases, equipment and construction remained strong. Revenue was ¥933 million, up ¥85 million, or 10.1%, from the same quarter of the previous year. Gross profit also increased with higher revenue. Despite higher personnel and other costs to strengthen sales capabilities, segment profit (operating profit) was ¥9 million, compared with a loss of ¥3 million in the same quarter of the previous year.」
Revenue increased 10.1% on sales across all categories, and the segment moved from an operating loss of ¥3 million in the same quarter of the previous year to operating profit of ¥9 million. - FY2018Full-year revenue growth and shift to an operating lossAnnual report
「The medical and industrial gas business recorded strong sales in each category of home healthcare equipment rentals, medical gases, industrial gases, equipment and construction. Revenue from the Chubu and Kyushu offices opened in the previous fiscal year also contributed, resulting in revenue of ¥3,689 million, up ¥324 million, or 9.7%, from the previous fiscal year. Gross profit also increased with higher sales, but increased selling expenses for medical gas cylinders and other items, as well as higher expenses including personnel costs, resulted in a segment loss (operating loss) of ¥72 million, compared with profit of ¥21 million in the previous fiscal year.」
Revenue increased 9.7% on contributions from the Chubu and Kyushu offices, while higher expenses including selling and personnel costs resulted in a shift from operating profit of ¥21 million in the previous fiscal year to an operating loss of ¥72 million. - FY2018-Q3Revenue growth and widening operating lossAnnual report
「In this segment, sales in each category of home healthcare equipment, including oxygen concentrators, medical gases, industrial gases, equipment and construction remained strong. Revenue from the Chubu and Kyushu offices opened in the previous fiscal year also contributed, resulting in revenue of ¥2,669 million, up ¥217 million, or 8.9%, from the same quarter of the previous year. Gross profit also increased with higher sales, but initial investments in medical gas cylinders and home healthcare equipment for new medical institution customers, as well as higher personnel costs associated with strengthening sales capabilities, resulted in a segment loss (operating loss) of ¥36 million, a decline of ¥40 million from the same quarter of the previous year.」
Revenue increased 8.9% on contributions from the Chubu and Kyushu offices, while initial investments for new medical institution customers and higher personnel costs expanded the operating loss to ¥36 million. - FY2018-Q2Revenue growth and operating lossAnnual report
「In this segment, rentals of home healthcare equipment, including oxygen concentrators, and sales of medical gases and industrial gases remained strong, as in the first quarter. Revenue from the Chubu and Kyushu offices opened in the previous fiscal year also contributed, resulting in revenue of ¥1,749 million, up ¥122 million, or 7.5%, from the same quarter of the previous year. Gross profit also increased with higher sales, but investments in home healthcare equipment and higher personnel costs associated with strengthening sales capabilities, among other factors, resulted in a segment loss (operating loss) of ¥8 million, a decline of ¥11 million from the same quarter of the previous year.」
Revenue increased 7.5%, including contributions from the Chubu and Kyushu offices, while investments in home healthcare equipment and personnel costs for strengthening sales capabilities resulted in an operating loss of ¥8 million, compared with profit in the same quarter of the previous year. - FY2018-Q1First-quarter revenue growth and narrower lossAnnual report
「In this segment, rentals of home healthcare equipment, including oxygen concentrators, and sales of medical gases, including oxygen, carbon dioxide and nitrogen, and industrial gases remained strong. Revenue from the Chubu and Kyushu offices opened in the previous fiscal year also contributed, resulting in revenue of ¥847 million, up ¥60 million, or 7.6%, from the same quarter of the previous year. Gross profit also increased with higher sales, but investments in home healthcare equipment and higher personnel costs associated with strengthening sales capabilities, among other factors, resulted in a segment loss (operating loss) of ¥3 million, compared with a loss of ¥12 million in the same quarter of the previous year.」
Revenue increased 7.6%, while investments in home healthcare equipment and higher personnel costs reduced the operating loss from ¥12 million in the same quarter of the previous year to ¥3 million. - FY2017Full-year revenue growth, lower profitAnnual report
「In this segment, rentals of home healthcare equipment, including oxygen concentrators, and sales of medical gases, including oxygen, and industrial gases, including carbon dioxide and nitrogen, remained strong. Revenue at the subsidiary 近畿酸素㈱ also grew steadily, resulting in revenue of ¥3,364 million, up ¥204 million, or 6.5%, from the previous fiscal year. Gross profit also increased with higher sales, but increased selling expenses for medical gas cylinders and other items, as well as higher expenses including personnel costs related to opening two new offices in Chubu and Kyushu, resulted in segment profit (operating profit) of ¥21 million, down ¥10 million, or 33.6%, from the same quarter of the previous year.」
Revenue increased 6.5% on higher sales of home healthcare equipment, medical gases and industrial gases, while operating profit decreased 33.6% due to cylinder selling expenses and costs related to the newly opened offices. - FY2017-Q3Continued revenue growth and lower profitAnnual report
「In this segment, sales in each category of home healthcare equipment, including oxygen concentrators, medical gases, industrial gases, equipment and construction remained strong. Revenue at the subsidiary 近畿酸素㈱ also grew steadily, resulting in revenue of ¥2,451 million, up ¥217 million, or 9.7%, from the same quarter of the previous year. Gross profit also increased with higher sales, but increased selling expenses for medical gas cylinders and other items, as well as higher expenses including personnel costs related to opening two new offices in Chubu and Kyushu, resulted in segment profit (operating profit) of ¥3 million, down ¥9 million, or 73.9%, from the same quarter of the previous year.」
Revenue increased 9.7% on higher sales of home healthcare equipment, medical gases and industrial gases, while operating profit decreased 73.9% due to cylinder selling expenses and costs related to the newly opened offices. - FY2017-Q2Revenue growth, lower profitAnnual report
「In this segment, rentals of home healthcare equipment, including oxygen concentrators, and sales in each category of medical gases, industrial gases, equipment and construction remained strong, as in the first quarter. Revenue at the subsidiary 近畿酸素㈱ also grew steadily, resulting in revenue of ¥1,627 million, up ¥160 million, or 11.0%, from the same quarter of the previous year. Gross profit also increased with higher sales, but increased selling expenses for medical gas cylinders and other items, as well as higher expenses including personnel costs related to opening two new offices in Chubu and Kyushu, resulted in segment profit (operating profit) of ¥2 million, down ¥12 million, or 81.1%, from the same quarter of the previous year.」
Revenue increased 11.0% on higher sales of home healthcare equipment, medical gases and industrial gases, while operating profit decreased 81.1% due to cylinder selling expenses and costs related to the newly opened offices. - FY2017-Q1Revenue growth and widening losses coexistedAnnual report
「Rentals of home healthcare equipment, including oxygen concentrators, and sales in each category of medical gases, industrial gases, equipment and construction remained strong. Revenue was ¥787 million, up ¥76 million, or 10.7%, from the same quarter of the previous year. Gross profit also increased with higher sales, but increased selling expenses for medical gas cylinders and other items, as well as higher expenses including personnel costs related to opening two new offices in Chubu and Kyushu, resulted in a segment loss (operating loss) of ¥12 million, compared with a loss of ¥2 million in the same quarter of the previous year.」
Sales increased across all categories and revenue rose 10.7%, but the operating loss widened from ¥2 million in the same quarter of the previous year to ¥12 million due to cylinder selling expenses and costs related to the newly opened offices. - FY2016First statedAnnual report
「In this segment, rentals of home healthcare equipment, including oxygen concentrators, and sales of medical gases, including oxygen, and industrial gases, including carbon dioxide and nitrogen, remained strong. Revenue was ¥3,159 million, up ¥62 million, or 2.0%, from the previous fiscal year. Gross profit also increased with higher sales and improved productivity at the Nara Sales Office and the high-pressure gas filling facilities of 近畿酸素㈱. As a result, segment profit (operating profit) was ¥32 million, up ¥3 million, or 11.4%, from the previous fiscal year.」
Sales of home healthcare equipment, medical gases and industrial gases increased, and the productivity improvements at the filling facilities of the Nara Sales Office and 近畿酸素㈱ were also noted.